Interstitial collagenases as markers of tumor progression.
about
Comparative study of matrix metalloproteinase expression between African American and Caucasian WomenTranscriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors.In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration.Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk.A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern ChinaSynergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesionsAge-dependent increases in interstitial collagenase and MAP Kinase levels are exacerbated by superoxide dismutase deficienciesStudy of matrix metalloproteinases and their inhibitors in prostate cancer.Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?MMP-1 expression has an independent prognostic value in breast cancer.Gene profiling analysis for patients with oral verrucous carcinoma and oral squamous cell carcinoma.CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasionHuman retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseRetinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms.Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.Physiology and pathophysiology of matrix metalloproteases.Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.Sequential morphological characteristics of murine fetal liver hematopoietic microenvironment in Swiss Webster mice.No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China.The influence of type 2 diabetes mellitus on the expression of inflammatory mediators and tissue inhibitor of metalloproteinases-2 in human chronic periodontitisMatrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells.Down regulation of MiR-93 contributes to endometriosis through targeting MMP3 and VEGFAc-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathwaysMatrix metalloprotease-1a promotes tumorigenesis and metastasis.
P2860
Q24804813-3DB85829-65CE-41E9-89CE-1FE37A624FFFQ24806147-314917C6-878E-4296-9806-86849D7FE195Q25257233-816B1A72-10F3-4E45-A807-57407F8E6448Q28469505-B1F49123-393F-4C94-80C0-1C8BA732EF3AQ31149571-A8F709CA-DEAB-4148-B213-A0C7DCF0A06CQ33301753-FAB85B5C-8524-4AD0-AD5B-AA436BD0C061Q33357902-A4997A00-19C1-4CCD-B92A-638AFA5C7A57Q33394405-B7571252-1C76-4644-AFAE-E72AB6C097CEQ33579360-191DD025-E8E7-4B70-979D-2087793E409AQ33632650-C11354B1-0078-4F38-A21B-148E7AF28DEEQ33682406-19A5D6E5-BD8C-481F-8E72-CA3061246597Q33708162-34322114-543F-44B7-B61C-B46CBF72ED80Q33758871-2955DF06-2198-4AEF-B4C6-001AD6D39379Q33947759-11793AE2-0D67-460C-A0AD-0724BE4009CAQ33990937-730152BD-43EE-40B3-AE78-F65BBB23BE44Q33991012-05B2F01F-6103-4506-A8D9-EFACA95C5EE3Q34042296-1E4663E3-BDA9-48C3-8B64-FAD7E5C44DE3Q34081818-C9FE5D09-1D32-40BD-AB2C-97CB61C529A3Q34330943-DDFF84B6-5C16-434A-B66D-A0DF592D0754Q34330950-C09EA0DF-51DC-4831-B311-55AEF42F843EQ34415685-D827632E-D106-410C-840F-ED58555C01A6Q34475894-F297B008-6BA3-4A69-BC0A-4EDE17AF0DF4Q34581776-2F0D9491-781E-446A-998F-4BF885EAC12BQ34700849-5CA41403-3C28-4416-99DA-9E6F05763A8AQ35007715-66632D78-6D5E-4A3E-BECF-106FB336774EQ35008756-7503AAB7-EC99-467D-AC55-79211A4D2D76Q35009784-EF4F81F2-9393-438C-BCBE-28D70A9939B5Q35010157-80C32719-57E7-46BC-A1C5-FCAB721D23E9Q35113424-BD11CF5D-E8A7-4BC3-96B8-A3916DCE5533Q35221967-5E53142D-2453-4C3F-8A7D-C86ECFFFF0A6Q35596926-C04FF4B2-E080-4C0F-A56E-2C2D8830FC89Q35613476-BAED592D-C610-47AA-B822-EC0AD78D1FA8Q35683612-72617BDD-4789-4C77-8DB3-2BB87792B51FQ35783096-6FDE7F8F-88F1-4D19-AC18-38D9096332C0Q35791814-4A598450-EDFE-47D5-82FA-23F49CB2B31CQ35835227-4EBFD258-4F5A-412E-962B-0E32C0B2636AQ35887678-BE6A1152-EED3-4920-8F9C-809925F51FF2Q35922535-D8C1B846-0721-4CDC-8B13-64AD7760EDA6Q36089228-FB0A80CB-4852-4FD6-90FD-A38AA211B3B9Q36097959-0AA9E4B1-6420-4BBB-95F6-4D6F8CB58E18
P2860
Interstitial collagenases as markers of tumor progression.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Interstitial collagenases as markers of tumor progression.
@ast
Interstitial collagenases as markers of tumor progression.
@en
Interstitial collagenases as markers of tumor progression.
@nl
type
label
Interstitial collagenases as markers of tumor progression.
@ast
Interstitial collagenases as markers of tumor progression.
@en
Interstitial collagenases as markers of tumor progression.
@nl
prefLabel
Interstitial collagenases as markers of tumor progression.
@ast
Interstitial collagenases as markers of tumor progression.
@en
Interstitial collagenases as markers of tumor progression.
@nl
P2093
P1476
Interstitial collagenases as markers of tumor progression.
@en
P2093
Brinckerhoff CE
P304
P407
P577
2000-12-01T00:00:00Z